Researchers are re-examining how to protect immunocompromised populations against measles. This group, an estimated 4-6% of Canadians, has grown since the last outbreak due to advances in immunosuppressants.

Learn more w. Dr. Deepali Kumar, director of UHN's Ajmera Transplant Centre: